Antipodes Partners’s Ingersoll Rand IR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.8K Sell
619
-325
-34% -$25.1K ﹤0.01% 113
2026
Q1
$75.6K Buy
944
+442
+88% +$39K ﹤0.01% 99
2025
Q4
$39.8K Buy
502
+16
+3% +$1.26K ﹤0.01% 110
2025
Q3
$40.2K Buy
486
+173
+55% +$14.2K ﹤0.01% 99
2025
Q2
$26K Buy
313
+38
+14% +$3K ﹤0.01% 94
2025
Q1
$22K Sell
275
-38
-12% -$3.31K ﹤0.01% 94
2024
Q4
$28.3K Sell
313
-54
-15% -$5.38K ﹤0.01% 71
2024
Q3
$36K Hold
367
﹤0.01% 74
2024
Q2
$33.3K Buy
367
+17
+5% +$1.56K ﹤0.01% 69
2024
Q1
$33K Hold
350
﹤0.01% 66
2023
Q4
$27K Buy
+350
New +$23.9K ﹤0.01% 69

Other funds holding IR

Antipodes Partners's IR Position: Q2 2026 in Review

Antipodes Partners reduced its Ingersoll Rand (IR) stake by 34% in Q2 2026, selling an estimated $25.1K and leaving 619 shares worth $50.8K. The position accounts for ﹤0.01% of the portfolio, ranked #113.

Antipodes Partners first reported a position in IR in Q4 2023 and has held it in 11 quarters since. The position peaked at $75.6K in Q1 2026. 896 funds tracked by Wall St. Rank hold IR as of Q2 2026.

  • Antipodes Partners held 619 shares of Ingersoll Rand worth $50.8K as of Q2 2026.
  • Antipodes Partners sold 325 Ingersoll Rand shares in Q2 2026, an estimated $25.1K.
  • Ingersoll Rand made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #113 holding.
  • Antipodes Partners first reported a position in Ingersoll Rand in Q4 2023 and has held it in 11 quarters since.
  • Antipodes Partners's Ingersoll Rand position peaked at $75.6K in Q1 2026.
  • 896 funds tracked by Wall St. Rank held Ingersoll Rand as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.